Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life
Patients in this study will be recruited from the Gynecologic Oncology Clinic waiting area.
All participants (patients, family and clinical caregivers, control group women with no
cancer) in this study will take part in an interview to see how they feel about the
different side-effects of chemotherapy. The interview will involve reading short
descriptions of the side-effects and then answering some questions that ask for an opinion.
The actual interview will take about 30-45 minutes to complete. The interviews will either
take place in private conference rooms in the clinic or in private rooms at the Ambulatory
Treatment Center (ATC).
Patients will also be given quality of life and symptom assessment questionnaires. The
questionnaires are simple to read and quick to answer. The questionnaire takes about 15
minutes to complete.
The participant's involvement in this study is limited to the questionnaire/interview. Once
that is done, the participant is finished with the study.
This is an investigational study. A total of 288 people will take part in this study. All
will be enrolled at M. D. Anderson.
Observational Model: Case-Only, Time Perspective: Prospective
Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy.
Diane C. Bodurka, MD
M.D. Anderson Cancer Center
United States: Institutional Review Board
|UT MD Anderson Cancer Center||Houston, Texas 77030|